Vincerx Pharma

Vincerx Pharma is a recently established clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies aimed at addressing unmet medical needs in cancer treatment. Vincerx's executive team has assembled a management team of biopharmaceutical experts with significant experience in building and operating organizations to develop and deliver innovative medicines to patients. Vincerx's current pipeline products stem from an exclusive licensing agreement with Bayer, including a clinical-stage and follow-up small molecule drug program, as well as a preclinical-stage bioconjugation/next-generation antibody-drug conjugate platform.